amitriptyline has been researched along with Atrophy in 1 studies
Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.
Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MARIANI, E | 1 |
VELLA, G | 1 |
1 other study available for amitriptyline and Atrophy
Article | Year |
---|---|
[CLINICAL CONSIDERATIONS ON A CASE OF MANIC-DEPRESSIVE PSYCHOSIS IN MIDDLE AGE, WITH CORTICAL ATROPHY AND INTELLECTUAL DETERIORATION].
Topics: Amitriptyline; Atrophy; Bipolar Disorder; Brain Diseases; Cerebral Cortex; Humans; Imipramine; Memor | 1963 |